March 22, 2024

OncLive and Targeted Oncology covered research presented by the University of Cincinnati's Thomas Herzog that found patients with perivascular epithelioid sarcoma (PEComa) of gynecologic or peritoneal origin experienced rapid, durable responses when treated with the drug nab-sirolimus.

April 13, 2023

The University of Cincinnati's Amanda Jackson joined 55KRC's Simply Medicine program to discuss the UP-NEXT ovarian cancer clinical trial.

January 3, 2023

The University of Cincinnati's Caroline Billingsley, MD, was featured in a Q&A article on OncLive discussing the use of antibody-drug conjugates in ovarian cancer treatment.